全文获取类型
收费全文 | 419篇 |
免费 | 30篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 25篇 |
妇产科学 | 5篇 |
基础医学 | 57篇 |
口腔科学 | 2篇 |
临床医学 | 54篇 |
内科学 | 113篇 |
皮肤病学 | 4篇 |
神经病学 | 33篇 |
特种医学 | 34篇 |
外科学 | 26篇 |
综合类 | 18篇 |
预防医学 | 30篇 |
药学 | 26篇 |
肿瘤学 | 24篇 |
出版年
2022年 | 5篇 |
2021年 | 9篇 |
2017年 | 6篇 |
2016年 | 3篇 |
2015年 | 9篇 |
2014年 | 7篇 |
2013年 | 15篇 |
2012年 | 7篇 |
2011年 | 16篇 |
2010年 | 9篇 |
2009年 | 15篇 |
2008年 | 10篇 |
2007年 | 8篇 |
2006年 | 10篇 |
2005年 | 19篇 |
2004年 | 8篇 |
2003年 | 15篇 |
2002年 | 9篇 |
2001年 | 12篇 |
2000年 | 13篇 |
1999年 | 11篇 |
1998年 | 21篇 |
1997年 | 18篇 |
1996年 | 15篇 |
1995年 | 15篇 |
1994年 | 10篇 |
1993年 | 4篇 |
1992年 | 9篇 |
1991年 | 9篇 |
1990年 | 9篇 |
1989年 | 5篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 7篇 |
1983年 | 3篇 |
1981年 | 4篇 |
1979年 | 4篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1976年 | 7篇 |
1975年 | 5篇 |
1974年 | 3篇 |
1973年 | 8篇 |
1971年 | 6篇 |
1970年 | 4篇 |
1969年 | 4篇 |
1968年 | 5篇 |
1967年 | 5篇 |
排序方式: 共有452条查询结果,搜索用时 15 毫秒
101.
Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia 总被引:12,自引:2,他引:12
The p16 gene, also referred to as MTS1, INK4, CDK4I, or CDKN2, at chromosome 9p21 has recently been described as a tumor suppressor that may be involved in a wide range of tumors. We have used a semiquantitative multiplex polymerase chain reaction assay to search for deletions of the p16 gene in 34 patients with chronic myeloid leukemia in blast crisis (CML BC), 19 patients with acute lymphoblastic leukemia (ALL), and 25 patients with acute myeloid leukemia (AML). Homozygous deletions of p16 exons were found in 5 of 10 (50%) patients with CML in lymphoid BC and in 5 (26%) ALL patients, but in only 1 (2%) case with AML. No deletions were found in CML BC of nonlymphoid phenotype. Comparison of chronic phase DNA or remission DNA with acute leukemia DNA in 5 individuals showed that the p16 deletions were acquired and not inherited, directly implicating these lesions in the pathogenesis of the disease. We conclude that functional elimination of the p16 gene, or a closely mapping gene, is involved in a significant number of patients with CML in lymphoid transformation. 相似文献
102.
Victor F. Froelicher Jr. MAJ USAF MC Mary M. Thomas USAF NC Lt Col. Charles Pillow S SGT USAF Malcolm C. Lancaster FACC COL. USAF MC 《The American journal of cardiology》1974,34(7):770-776
A group of 1,390 asymptomatic men screened for latent coronary artery disease by maximal treadmill testing and double Master two-step test were followed up for a mean of 6.3 years. Angina, sudden death or acute myocardial infarction was used as the end point for coronary heart disease. There were differences in testing sensitivity and specificity among age and subject groups, but maximal treadmill testing out-performed the double Master test as a screening technique. Maximal treadmill testing demonstrated a 60.9 percent sensitivity, 92 percent specificity and a 20 percent probability that coronary artery disease would develop in a subject with an abnormal response. A risk ratio of 14.3 was obtained and demonstrated that maximal treadmill testing was a valuable screening technique for latent coronary artery disease. However, limitations of the sensitivity and specificity of the functional S-T segment response were apparent. The abnormal S-T segment response to exercise testing did not absolutely predict the future presentation of coronary artery disease, and a normal response to maximal treadmill testing did not rule out this possibility. Because premature ventricular contractions demonstrated a very low sensitivity, predictive value and risk ratio they were not a practical indicator of increased risk for latent coronary artery disease except when associated with an abnormal S-T segment response. 相似文献
103.
Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1 总被引:13,自引:1,他引:13
Tissue inhibitor of metalloproteinases-1 (TIMP-1), the major physiological matrix metalloproteinase inhibitor and a potent antimetastatic factor, also stimulates the growth of erythroid progenitors (erythroid-potentiating activity). We analyzed the relationship between the growth factor activity and protease inhibition by preparing purified TIMP-1 "knockout" proteins lacking in vitro antiproteolytic activity. The growth-stimulatory effect of these N- terminal TIMP-1 point mutants, as tested in an in vitro assay using erythroid precursors (erythroid burst-forming units) was equal to that of unmutated TIMP-1. A fully antiproteolytic C-terminal TIMP-1 truncation also stimulated growth in the erythroid burst-forming unit assay. The results indicate that the influence of TIMP-1 on erythroid precursor growth is independent of its ability to inhibit metalloproteinases. TIMP-1 is analogous to proteins that have both proteolytic and growth factor activity, such as plasmin, thrombin, and urokinase. However, TIMP-1 is novel in this regard because it is a metalloproteinase inhibitor. We show that the antiproteolytic and growth factor activities of the TIMP-1 molecule are physically and functionally distinct. 相似文献
104.
Nason-Burchenal K; Gandini D; Botto M; Allopenna J; Seale JR; Cross NC; Goldman JM; Dmitrovsky E; Pandolfi PP 《Blood》1996,88(10):3926-3936
105.
T Berry W Luther N Bhatnagar Y Jamin E Poon T Sanda D Pei B Sharma WR Vetharoy A Hallsworth Z Ahmad K Barker L Moreau H Webber W Wang Q Liu A Perez-Atayde S Rodig NK Cheung F Raynaud B Hallberg SP Robinson NS Gray AD Pearson SA Eccles L Chesler RE George 《Cancer cell》2012,22(1):117-130
The ALK(F1174L) mutation is associated with intrinsic and acquired resistance to crizotinib and cosegregates with MYCN in neuroblastoma. In this study, we generated a mouse model overexpressing ALK(F1174L) in the neural crest. Compared to ALK(F1174L) and MYCN alone, co-expression of these two oncogenes led to the development of neuroblastomas with earlier onset, higher penetrance, and enhanced lethality. ALK(F1174L)/MYCN tumors exhibited increased MYCN dosage due to ALK(F1174L)-induced activation of the PI3K/AKT/mTOR and MAPK pathways, coupled with suppression of MYCN pro-apoptotic effects. Combined treatment with the ATP-competitive mTOR inhibitor Torin2 overcame the resistance of ALK(F1174L)/MYCN tumors to crizotinib. Our findings demonstrate a pathogenic role for ALK(F1174L) in neuroblastomas overexpressing MYCN and suggest a strategy for improving targeted therapy for ALK-positive neuroblastoma. 相似文献
106.
本研究的目的是探讨血管紧张素受体抑制剂能否预防阿尔茨海默病和痴呆,或者减缓这两种疾病的病情进展。 相似文献
107.
108.
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma 总被引:4,自引:0,他引:4
Chesler L Goldenberg DD Seales IT Satchi-Fainaro R Grimmer M Collins R Struett C Nguyen KN Kim G Tihan T Bao Y Brekken RA Bergers G Folkman J Weiss WA 《Cancer research》2007,67(19):9435-9442
Targeted expression of MYCN to the neural crest [under control of the rat tyrosine hydroxylase (TH) promoter] causes neuroblastoma in transgenic mice (TH-MYCN) and is a well-established model for this disease. Because high levels of MYCN are associated with enhanced tumor angiogenesis and poor clinical outcome in neuroblastoma, we serially characterized malignant progression, angiogenesis, and sensitivity to angiogenic blockade in tumors from these animals. Tumor cells were proliferative, secreted high levels of the angiogenic ligand vascular endothelial growth factor (VEGF), and recruited a complex vasculature expressing the angiogenic markers VEGF-R2, alpha-SMA, and matrix metalloproteinases MMP-2 and MMP-9, all of which are also expressed in human disease. Treatment of established murine tumors with the angiogenesis inhibitor TNP-470 caused near-complete ablation, with reduced proliferation, enhanced apoptosis, and vasculature disruption. Because TNP-470 has been associated with neurotoxicity, we tested the recently described water-soluble HPMA copolymer-TNP-470 conjugate (caplostatin), which showed comparable efficacy and was well tolerated without weight loss or neurotoxicity as measured by rotarod testing. This study highlights the importance of angiogenesis inhibition in a spontaneous murine tumor with native tumor-microenvironment interactions, validates the use of mice transgenic for TH-MYCN as a model for therapy in this common pediatric tumor, and supports further clinical development of caplostatin as an antiangiogenic therapy in childhood neuroblastoma. 相似文献
109.
110.
Haupt R Spinetta JJ Ban I Barr RD Beck JD Byrne J Calaminus G Coenen E Chesler M D'Angio GJ Eiser C Feldges A Gibson F Lackner H Masera G Massimo L Magyarosy E Otten J Reaman G Valsecchi MG Veerman AJ Penn A Thorvildsen A van den Bos C Jankovic M;International Berlin-Frankfurt-Münster Study Group Early Late Toxicity Educational Committee 《European journal of cancer (Oxford, England : 1990)》2007,43(12):1778-1780
The number of subjects that have successfully completed treatment for a cancer diagnosed during childhood and are entering adulthood is increasing over time. Members of the International Berlin-Frankfurt-Munster (I-BFM) Early and Late Toxicity Educational Committee (ELTEC) invited 45 paediatric cancer experts (representing oncologists, psychologists, nurses, epidemiologists, parents, and survivors) from 13 European countries (with five additional experts from North America) to Erice, Sicily (from October 27 to 29, 2006) to discuss the circumstances in which the word 'cure' should be used when speaking about children with cancer, and when and why continuing follow-up and care may be required. The objective of the gathering was to generate from the personal and professional experience of the participants an overview statement of the group's philosophy of cure and care of survivors of childhood cancer. The ten points reflect what the group considers essential in the survivors' cure and care. 相似文献